Stand out for this role — generate a tailored resume and cover letter in about a minute.
Replimune seeks a Director, HR Business Partner to lead HRBP support for Milton Park, UK, working closely with leaders and the HR team. The role drives employee relations, performance management, onboarding and development to support rapid business growth.
The role requires on-site presence at least four days per week in Milton Park, with 10–15% travel to the Boston area. Strong biotech/BD experience is highly valued.
Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it.
At Replimune, we live by our values:
United: We Collaborate for a Common Goal.
Audacious: We Are Bold.
Dedicated: We Give Our Full Commitment.
Candid: We Are Honest With Each Other.
People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward‑looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.
The Director, HR Business Partner (HRBP) provides HR leadership and expert support to Replimune leaders and employees in our Milton Park, UK site. With the support of the broader HR team, the Director will be responsible for a broad range of human capital matters for this site, from employee relations and performance management to onboarding and development. The HR Business Partner is a resource to employees and managers and liaises with other internal functions when needed to bring solutions to clients. The Director, HRBP is expected to play a key role in developing and implementing HR programs and practices to help grow the business, contribute to the development of leaders and people managers, and drive employee engagement.
The Director, HRBP role requires at least four days per week on‑site in Milton Park, UK. Additionally, 10-15% travel required to the Boston area of the United States.
Undergraduate degree required, Master’s degree preferred
10+ years of broad Human Resources experience with significant exposure to employee relations, performance management, talent acquisition and other HR disciplines (e.g., training, benefits)
3+ years of experience in roles working directly with senior leaders as internal clients in an HR business partner capacity.
Experience in the Biotech industry or within a lab‑environment strongly preferred; familiarity with R&D functions also preferred.
Ability to effectively influence leaders and other stakeholders in an organization by demonstrating a high level of service, maturity, executive presence, and business acumen.
Strong operational and business acumen, with the ability to act as a business partner with senior leaders in helping them meet or exceed their strategic objectives and tactical goals; ability and willingness to shift quickly between the strategic and tactical on a daily basis.
Strong general knowledge of UK employment laws, employee compensation, benefits, payroll, recruiting, performance management and training.
Embraces the pace and opportunities of a fast‑growing organization and has proven ability to handle a broad range of responsibilities; strong project management and prioritization skills to effectively drive multiple projects and initiatives.
Possesses a high energy level, sense of urgency, ability to work hard and well under pressure and to effectively partner with the rest of the HR team.
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV‑1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti‑tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus‑mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options.
For more information, please visit www.replimune.com.
We are an Equal Opportunity Employer.